Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients — RLS

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Idiopathic Restless Legs Syndrome Clinical Trial

Official title:
Randomized, Double Blind, 12-Month Study Of Pregabalin In Subjects With Restless Legs Syndrome

Status Completed

Clinical Trial Summary

This purpose of this study is to investigate the efficacy and tolerability of pregabalin in treating idiopathic RLS patients for up to 12 months.

n/a

See also
Status	Clinical Trial	Phase
Completed	`NCT00390689` - A Randomised, Comparing Fixed Doses of Pramipexole to Investigate the Efficacy and Safety in Patients With RLS.	Phase 3
Completed	`NCT01113710` - Non-interventional Study (NIS) in Patients With Restless Legs Syndrome in Daily Practise	N/A
Completed	`NCT00666965` - A Placebo-Controlled Study for SPM 962 in Restless Legs Syndrome (RLS) Patients	Phase 2
Completed	`NCT00498108` - Phase 3 Open-label Extension Trial With Rotigotine in Idiopathic Restless Legs Syndrome Subjects	Phase 3
Completed	`NCT01084551` - Study of SPM 962 in Patients With Restless Legs Syndrome (RLS)	Phase 3
Completed	`NCT01562743` - A Long-Term Extension Trial From Late Phase II of SPM 962 in Patients With Restless Legs Syndrome	Phase 2